Gilead Sciences, a privately owned biotechnology research company founded in 1987 and headquartered in the US, employs approximately 13,690 people. The company's primary focus is the development and production of medicines for life-threatening diseases.
Moody's affirmed Gilead's A3 rating and revised the outlook to positive. Gilead was also named among the top 10 AI-powered biotech stocks to buy. Several Gilead lawyers—Devora Allon, Kevin Neylan, Kevin Jonke, Jay Lefkowitz, Cole Carter, John Christian Kasdin, Mitchell Yi Yuan, Hannah Putnam, and Yaffa Meeran—were recognized as runners-up for The American Lawyer Litigation Daily's "Litigator of the Week." A separate working paper reported that one-third of data points collected in 105 phase 2 and 3 trials were unnecessary for key analyses, highlighting the increased burden on patients and trial sites.
Similar Companies
Subscribe for full access to Gilead Sciences's profile
Gilead Sciences offers 2 products in the media and telecoms services industry. Gilead Sciences's product portfolio comprises of media and TV services.
Subscribe for full access to Gilead Sciences's products in full detail
Subscribe for full access to Gilead Sciences's revenue in full detail
Subscribe for full access to Gilead Sciences's products in full detail 
